|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01N 37/34 | |
| A61K 31/275 | |||
| C07D 231/12 | |||
| C07D 307/79 | |||
| C07D 405/06 | |||
| C07D 405/12 | |||
| C07D 405/14 | |||
| C07D 409/12 | |||
| C07D 417/12 | |||
| C07D 417/14 |
| (11) | Patento numeris | 2257160 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09712269.1 |
| Europos patento paraiškos padavimo data | 2009-02-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-12-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-07-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/034917 |
| Data | 2009-02-23 |
| (87) | Numeris | WO 2009/105776 |
| Data | 2009-08-27 |
| (30) | Numeris | Data | Šalis |
| 30541 | 2008-02-21 | US |
| (72) |
EISSENSTAT, Michael, US
DUAN, Dehui, US
|
| (73) |
Sequoia Pharmaceuticals, Inc.,
10388 Stanmore Drive, Potomac, MD 20854,
US
|
| (54) | DIAMIDE INHIBITORS OF CYTOCHROME P450 |
| DIAMIDE INHIBITORS OF CYTOCHROME P450 |